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Introduction
Cooking meat at high temperature and for 
a long duration produces several mutagenic 
compounds such as heterocyclic amines 





quinoxaline (DiMeIQx). Animal studies have 
provided sufficient evidence for their carci-
nogenic potential [Group 2B, International 
Agency for Research on Cancer (IARC)] of 
MeIQx, DiMeIQx, and PhIP (IARC 1993; 
NTP 2014); however, in humans, epide-
miological data relating HCA intake to risk 
of colorectal cancer (CRC) are inconsis-
tent (Augustsson et al. 1999; Butler et al. 
2003; Cross et al. 2010; Gilsing et al. 2012; 
Helmus et al. 2013; Kobayashi et al. 2009; 
Le Marchand et al. 2002; Miller et al. 2013; 
Nöthlings et al. 2009; Nowell et al. 2002; 
Ollberding et al. 2012; Joshi et al. 2015). 
Given the paucity of prospective data relating 
HCA intake to CRC, we used data from the 
Nurses’ Health Study (NHS) and Health 
Professionals Follow-up Study (HPFS) to 
investigate the association between meat 
mutagen intake and risk of CRC. The long 
follow-up (14 years) and large number of cases 
also allowed us to assess associations by sub-
sites and to conduct lagged analyses with suffi-
cient statistical power. Our specific hypotheses 
were that a) higher intake of meat mutagens 
would be associated with higher risk of CRC, 
and b) associations between meat mutagens 
and CRC would vary by cancer sub-sites and 
by latency period between exposure and disease.
Methods
Study Population
We used data from two large prospective 
cohort studies: the HPFS, which included 
51,529 U.S. male health professionals, 
40–75 years of age at enrollment in 1986; 
and the NHS, which included 121,700 U.S. 
female nurses, 30–55 years of age at enroll-
ment in 1976. More details on the cohorts 
and data collection can be found elsewhere 
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Background: Heterocyclic amines (HCAs) in cooked meats may play a role in colorectal cancer 
(CRC) development.
oBjectives: We aimed to prospectively examine the association between estimated intakes of 
HCAs and meat-derived mutagenicity (MDM) in two cohorts of health professionals, the Health 
Professionals Follow-up Study (HPFS) and the Nurses’ Health Study (NHS).
Methods:  In 29,615 men and 65,875 women,  intake of  the HCAs 2-amino-
3,8-dimethylimidazo(4,5-j)quinoxaline (MeIQx), 2-amino-1-methyl-6-phenylimidazo(4,5-b)
pyridine (PhIP), 2-amino-3,4,8-trimethylimidazo(4,5-f)quinoxaline (DiMeIQx), and MDM 
was estimated using a 1996 cooking questionnaire, the 1994 food frequency questionnaire, and 
an online database. Cox proportional hazards models were used to estimate hazard ratios (HRs) 
and 95% confidence intervals (CIs) and to adjust for potential confounders. Estimates for both 
cohorts were pooled using random-effects meta-analysis.
results: Between 1996 and 2010, 418 male and 790 female CRC cases were identified. Meat 
mutagen intake was not statistically significantly associated with risk of CRC [highest vs. lowest 
quintile, pooled HR (95% CI) for MeIQx: 1.12 (0.93, 1.34), p for trend 0.23; PhIP: 1.10 
(0.90, 1.33), p for trend 0.35; MDM: 1.03 (0.86, 1.24), p for trend 0.75] or subtypes of CRC 
defined by tumor location (proximal or distal colon, or rectum). When analyzed by source of meat, 
PhIP from red but not from white meat was nonsignificantly positively associated with CRC and 
significantly positively associated with proximal cancers [HR (95% CI) per standard deviation 
increase of log-transformed intake: PhIP red meat: CRC: 1.06 (0.99, 1.12), proximal: 1.11 (1.02, 
1.21); PhIP white meat: CRC: 0.99 (0.94, 1.04), proximal: 1.00 (0.93, 1.09)].
conclusions: Estimated intakes of meat mutagens were not significantly associated with CRC risk 
over 14 years of follow-up in the NHS and HPFS cohorts. Results for PhIP from red but not from 
white meat warrant further investigation.
citation: Le NT, Michels FA, Song M, Zhang X, Bernstein AM, Giovannucci EL, Fuchs CS, 
Ogino S, Chan AT, Sinha R, Willett WC, Wu K. 2016. A prospective analysis of meat mutagens 
and colorectal cancer in the Nurses’ Health Study and Health Professionals Follow-up Study. 
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(Colditz et al. 1997; Rimm et al. 1991). In 
brief, at baseline and then every 2 years there-
after, participants in both cohorts received 
questionnaires inquiring about medical 
history and lifestyle. The study protocol was 
approved by the Human Subjects Committee 
of the Brigham and Women’s Hospital and the 
Harvard T.H. Chan School of Public Health. 
Completion and return of the  questionnaires 
was considered implied consent.
Assessment of Diet
Dietary information was obtained from 
validated semi-quantitative food frequency 
questionnaires (FFQ) (Feskanich et al. 1993; 
Rimm et al. 1992; Salvini et al. 1989; Willett 
et al. 1985). In the HPFS, a 131-item FFQ 
was administered at the time the cohort was 
established in 1986, follow-up FFQs were 
mailed every 4 years (e.g., 1990, 1994, 1998). 
In the NHS, FFQs were administered in 
1984, 1986 and then every 4 years thereafter 
(e.g., 1990, 1994, 1998). Because the cooking 
questionnaire was administered during a 
non-FFQ follow-up questionnaire cycle 
in 1996 (start of follow-up for this current 
study), intake of nutrients such as calcium or 
folate or foods such as total red meat was esti-
mated using data from our FFQs. On each 
FFQ, participants were asked how often on 
average they ate a specific food item (using a 
specified portion size) during the past year. 
Participants were given nine categories of 
frequency of intake to choose from: never or 
< 1/month, 1–3/month, 1/week, 2–4/week, 
5–6/week, 1/day, 2–3/day, 4–5/day and 
≥ 6/day. We computed nutrient intake by 
multiplying the nutrient content of foods 
with the reported frequency of intake of each 
food from the FFQs and applied the residual 
method to calculate energy-adjusted nutrient 
intakes (Willett 2013a). Cumulative updated 
nutrient and diet intake was computed by 
averaging the intakes from all available FFQs 
up to the most recent 2-year follow-up 
cycle. We used cumulative intake to enhance 
our estimate of long-term dietary intake 
(Willett 2013b).
Assessment of HCA Intake
To better estimate HCA intake in our 
cohorts, we previously conducted a pilot 
study (Byrne et al. 1998). In that study, we 
mailed a four-page cooking questionnaire 
inquiring about frequency of intake of 18 
food/cooking method combinations as well as 
doneness of each item (questions were devel-
oped in collaboration with R. Sinha from 
the National Cancer Institute), to a random 
sample of 250 HPFS participants and 250 
NHS participants. Cooking questionnaires 
were returned by 226 NHS and 216 HPFS 
participants and then linked to HCA levels 
measured in cooked meat samples (Sinha 
et al. 1995, 1998; Sinha and Rothman 1997) 
to estimate HCA intake in each cohort.
Based on the results from the pilot study 
we developed a cooking questionnaire, 
which was included in the 1996 follow-up 
mailing. This cooking questionnaire inquired 
about the frequency of intake (i.e., never, 
< 1/month; 1/month, 2–3/month; 1/week, 
2–3/week; and ≥ 4/week) and doneness (i.e., 
lightly browned; medium browned; well 
browned; and blackened/charred) of cooked 
meats and fish [i.e., pan-fried, broiled, and 
grilled chicken; broiled fish; roast beef; pan-
fried steak (NHS only); pan-fried hamburger 
(HPFS only); grilled or barbecued steak; 
and homemade beef gravy]. We used the 
CHARRED Database (National Cancer 
Institute), an online database (NCI 2006) 
that contains data on heterocyclic amines and 
meat-derived mutagenicity (MDM), a marker 
for overall meat mutagen exposure, which 
was measured using the Ames Salmonella test 
(Ames et al. 1975). Consumption of meat 
mutagens was estimated by multiplying 
the frequency of cooked meat intake from 
the cooking questionnaires with measured 
individual heterocyclic amine (ng/g meat) 
or MDM levels (revertant colonies/g meat) 
and standard (medium) portion size from the 
CHARRED Database (NCI 2006). Meat 
mutagen intake for bacon (HPFS and NHS) 
and hamburger (NHS only) was estimated 
using intake data from the 1994 FFQ, which 
is the FFQ closest to 1996. For more detail 
on those calculations in the HPFS and NHS, 
please refer to our previous publications (Wu 
et al. 2006, 2010).
Case and Death Ascertainment
When a participant reported a diagnosis 
of CRC on the biennial questionnaire, we 
requested permission from the participant 
to obtain and review medical records. Study 
investigators blinded to the exposure status 
extracted information on stage, site, and 
histology of CRC (Bernstein et al. 2015; 
Zhang et al. 2012). We identified deaths by 
reviewing the National Death Index, the state 
vital statistics record, and death certificates 
that were mailed by next of kin of deceased 
participants with > 96% sensitivity (Rich-
Edwards et al. 1994; Stampfer et al. 1984). 
For nonrespondents who died of CRC, we 
also requested permission to obtain medical 
records from the next of kin. After review of 
those medical records by study investigators 
we were able to confirm a diagnosis of CRC 
in over 98% of deceased nonrespondents who 
died of CRC in both cohorts.
Exclusion Criteria
Participants were ineligible for this study if 
they a) had reported a history of any cancer 
(except for non-melanoma skin cancer) or 
ulcerative colitis before 1996, b) had calculated 
energy intake of < 800 or > 4,200 kcal/day in 
men, or < 600 or > 3,500 kcal/day in women, 
or c) had left the entire cooking method 
section on the 1996 questionnaire blank. In 
addition, we also excluded participants for 
whom HCAs/MDM could not be calcu-
lated due to missing information on bacon 
or hamburger intake in the 1994 FFQ or 
had reported information on doneness of 
cooked meat but not on frequency of cooked 
meat intake.
Statistical Analyses
Each participant contributed person-years 
from the date of return of the 1996 follow-up 
questionnaire to the end of our follow-
up period (31 January 2010 for HPFS and 
30 May 2010 for NHS), date of death, or 
CRC diagnosis, whichever occurred first. 
Intakes of HCAs and MDM were divided 
into cohort-specific quintiles. To examine 
the association between quintiles of meat 
mutagen intake and risk of CRC, we used a 
Cox proportional hazards model to estimate 
hazard ratios (HRs) and 95% confidence 
intervals (CIs). In multivariable models, 
we adjusted for age (in months) and other 
known and suspected risk factors for CRC. 
Covariates were derived from our repeated 
follow-up lifestyle and medical history ques-
tionnaires and FFQs and included family 
history of CRC in first-degree relatives (yes 
vs. no), prior lower gastrointestinal endoscopy 
(sigmoidoscopy or colonoscopy; yes vs. no), 
pack-years of smoking before age 30 years 
(0, 0.1–4.9, 5–9.9, ≥ 10), body mass index 
(BMI; kg/m2: < 23, 23–24.9, 25–26.9, 
27–29.9, ≥ 30), leisure time physical activity 
[metabolic equivalent (METs)–hr/week: < 3, 
3–8.9, 9–17.9, 18–26.9, ≥ 27], regular aspirin 
or NSAID (non steroidal  anti- inflammatory 
drugs) use (≥ 2 tablets/week), total caloric 
intake (quintiles), alcohol consumption 
(g/day: < 5, 5–9.9, 10–14.9, 15–29.9, ≥ 30). 
To assess whether observed associations may 
be explained by meat or fish intake per se or 
components of meat, we also ran additional 
models after including intake of total red 
meat, unprocessed red meat, processed meat, 
chicken/turkey, fish, and total saturated fat 
intake (all in quintiles) separately to the multi-
variable models. Because other dietary factors 
such as calcium, folate, or fiber intake have 
also been suggested as risk factors for CRC, 
we also ran models after adjusting for total 
calcium, total fiber, and total folate intake (in 
quintiles) separately. We added each dietary 
variable separately to the models because of 
possible colinearity between dietary factors. 
Because there is evidence suggesting a role for 
heme iron in colorectal carcinogenesis (heme 
iron can increase production of carcinogenic 
N-nitroso compounds) (Bastide et al. 2015; 
Meat mutagen intake and colorectal cancer
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Cross and Sinha 2004), we also ran analyses 
after including heme iron intake to the multi-
variable models. A test for trend was calcu-
lated by treating the median of each quintile 
of the exposure variable as a continuous 
variable in the model and using a Wald test 
to assess statistical significance. Risk estimates 
from both cohorts were pooled by utilizing 
random-effects meta-analysis (DerSimonian 
and Laird 1986).
We also examined associations between 
meat mutagen intake and sub-sites of CRC 
using meat mutagen intake as a continuous 
variable [per standard deviation (SD) of 
log (natural logarithm)–transformed meat 
mutagen intake]. To assess whether asso-
ciations may differ by risk factors for CRC, 
we also conducted analysis after stratification 
by BMI (< 25 kg/m2/≥ 25 kg/m2), smoking 
status (never/ever), and family history of CRC 
in first-degree relatives (yes/no). Tests for 
interaction were conducted by including cross-
product terms of the stratification variable 
(binary) and HCAs or MDM (continuous) 
in the models and using a Wald test to assess 
statistical significance. We also examined 
whether frequency of meat intake cooked using 
a specific cooking method (proxy for tempera-
ture of cooking) such as pan-frying, broiling, 
grilling, barbequing, or roasting (roast beef) 
and outside appearance (proxy for duration of 
cooking; well-browned or  blackened/charred 
vs. lightly browned or medium browned) were 
associated with CRC.
To examine risk of CRC 0–4 years after 
exposure, we limited our analyses to cases 
diagnosed between 1996 and 2000, and for 
the 4–14 year lagged analyses we limited our 
analyses to cases diagnosed between 2000 
and 2010. A two sided p-value < 0.05 was 
 considered statistically significant.
Results
Between 1996 and 2010, we identified 
418 CRC cases in men and 790 in women 
through follow-up of 29,615 men and 
65,785 women. Lowest, median, and highest 
intakes of HCA and MDM in each quintile 
are depicted in Table S1. Median and SD 
of the log-transformed meat mutagen intake 
are presented in Table S2. Because lifestyle 
and dietary factors may differ by age, baseline 
characteristics for participants by PhIP 
and MDM intake were age-standardized 
(Table 1). Generally, participants with lower 
intake of PhIP and MDM were more likely to 
adhere to a healthier lifestyle and diet: They 
tended to have lower BMI and were more 
likely to use multivitamins and had lower 
intakes of total red meat, animal protein, 
heme iron, and alcohol, but higher intake of 
folate, calcium, vitamin D, and dietary fiber. 
In addition, participants with higher meat 
mutagen intake were also more likely aspirin 
or NSAID users (Table 1). Participants with 
lower MDM were also more likely to undergo 
lower bowel  endoscopy and be more physi-
cally active. Baseline characteristics by MeIQx 
and DiMeIQx intake were similar to those 
presented for PhIP (data not shown).
In age-adjusted models, DiMeIQx and 
MDM intake was not significantly associated 
Table 1. Age-standardized baseline characteristics of study participants in the Health Professionals Follow-up Study (n = 29,615) and the Nurses’ Health Study 
(n = 65,785) by PhIP and MDM intake [HCA quintiles (Q)].a
Characteristicb
HPFS NHS
PhIP-Q1 PhIP-Q5 MDM-Q1 MDM-Q5 PhIP-Q1 PhIP-Q5 MDM-Q1 MDM-Q5
Number of observations 5,923 5,934 5,923 5,923 13,157 13,157 13,157 13,157
Age (years) 63.5 62.8 63.4 63.0 62.3 62.0 62.2 62.1
Body mass index (kg/m2) 24.9 25.9 24.9 25.9 25.6 27.3 25.4 27.4
Body mass index 
< 25 kg/m2 (%) 56.5 40.7 56.9 41.7 59.0 45.8 61.0 44.6
≥ 25 kg/m2 (%) 43.5 59.3 43.1 58.3 41 54.2 39 55.4
Physical activity, MET-hr/week 34.2 34.1 34.3 33.2 19.2 16.9 20.3 15.7
Pack-years of smoking before age 30 years 10.5 11.6 10.7 11.5 7.0 7.2 7.0 7.2
Smoking status
Never (%) 48.8 43.8 49.3 43.6 47.6 41.5 46.9 43.2
Ever (%) 51.2 56.2 50.7 56.4 52.4 58.5 53.1 56.8
Family history of colorectal cancer in first-degree relative (%) 16.0 14.9 15.8 14.5 17.3 18.4 17.5 18.4
Prior lower bowel endoscopy (sigmoidoscopy or colonoscopy) (%) 28.2 27.1 29.3 24.5 18.7 17.6 19.7 17.3
Current multivitamin use (%) 57.7 52.4 56.6 51.7 56.2 50.1 57.1 50.2
Regular aspirin or NSAID use ≥ 2 tablets/week) (%) 53.2 59.2 53.0 57.7 48.9 56.4 49.1 56.1
Postmenopausal (%) — — — — 91.1 91.4 91.0 91.3
Current postmenopausal hormone use (%)c — — — — 66.8 68.2 68.9 66.2
Total red meat intake (g/day) 42.7 89.0 38.4 100.1 40.6 81.4 35.8 87.1
Unprocessed red meats (servings/day) 0.3 0.7 0.3 0.8 0.3 0.6 0.3 0.7
Processed red meats (servings/day) 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.4
Poultry (servings/day) 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.4
Fish (servings/day) 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Total fruits (servings/day) 2.8 2.5 2.8 2.4 2.4 2.3 2.5 2.2
Total vegetables (servings/day) 3.2 3.3 3.2 3.2 3.0 3.2 3.1 3.1
Alcohol consumption (g/day) 2.0 2.5 2.0 2.4 4.8 7.3 5.3 6.6
Animal protein (g/day) 58.9 67.0 59.4 66.4 53.7 56.8 54.0 55.8
Vegetable protein (g/day) 28.9 25.0 28.9 24.7 20.4 18.3 20.5 18.3
Folate (μg/day) 555.7 490.6 555.7 481.1 441.3 387.1 446.8 380.7
Calcium (mg/day) 992.0 847.2 985.1 858.6 1031.1 880.6 1046.8 870.4
Vitamin D (IU/day) 472.2 412.6 478.3 403.6 379.6 319.6 383.1 315.3
Dietary fibers (g/day) 24.8 21.0 25.0 20.5 18.5 16.0 18.7 15.7
Saturated fat (g/day) 20.7 23.8 20.4 24.5 20.2 22.4 19.8 22.7
Heme iron (mg/day) 1.0 1.4 1.0 1.4 1.0 1.2 1.0 1.2
Cholesterol (mg/day) 237.0 292.8 236.6 298.6 242.3 277.4 240.4 275.9
Total calorie intake (kcal/day) 1840.1 2119.7 1802.4 2198.8 1606.0 1834.8 1590.7 1853.4
Abbreviations: MDM, meat-derived mutagenicity; MET, metabolic equivalent; PhIP, 2-amino-1-methyl-6-phenylimidazo pyridine; Q1, lowest quintile; Q5, highest quintile.
aConsumption of PhIP and MDM was estimated by multiplying the frequency of cooked meat intake from the cooking questionnaires with measured PhiP (ng/g meat) or MDM levels 
(revertant colonies/g meat) and standard (medium) portion size from the CHARRED Database (NCI 2006). bContinuous variables are presented as means; all values are age-standard-
ized except for age. cCalculated among postmenopausal women only. 
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with risk of CRC in the HPFS (Table 2). 
In men, but not in women, higher intake 
of MeIQx was significantly associated with 
higher risk of CRC [highest vs. lowest 
quintile: HR = 1.44 (95% CI: 1.07, 1.94), 
p for trend = 0.04], but associations were 
attenuated after multivariable adjustment 
and became nonsignificant [highest vs. lowest 
quintile: HR = 1.22 (95% CI: 0.89, 1.68), 
p for trend = 0.35, Table 2]. From here on, 
“HR” denotes multivariable-adjusted HRs 
unless noted otherwise. Total PhIP intake 
was not associated with risk of CRC in 
multivariable models; however, when PhIP 
intake was investigated separately by source, 
results suggested a positive, albeit nonsig-
nificant, association between PhIP from 
red meat in men and women as well as the 
pooled analysis [highest vs. lowest quintile, 
HR (95% CI): HPFS: 1.31 (0.93, 1.84), 
p for trend = 0.27; NHS: 1.15 (0.92, 1.45), 
p for trend = 0.14; pooled: 1.20 (0.99, 1.45), 
p for trend = 0.06; Table 2], but not from 
white meat. MeIQx and MDM from red 
meat were not significantly associated with 
risk of CRC [highest vs. lowest quintile, 
pooled HR (95% CI) for MeIQx from red 
meat: 1.12 (0.94, 1.35), p for trend = 0.21, 
for MDM from red meat 1.17 (0.97, 1.40), 
p for trend = 0.10] (data not shown). In 
addition when we examined meat mutagen 
intake as a continuous variable, higher intake 
of PhIP from red meat was nonsignificantly 
associated with an increased risk of CRC 
[pooled HR (95% CI) per SD increase of 
log-transformed intake: PhIP red meat: CRC: 
1.06 (0.99, 1.12), p = 0.07, PhIP white 
meat: CRC: 0.99 (0.94, 1.04), p = 0.61 (data 
not shown).
Associations between HCAs and CRC 
were similar after further adjusting for total 
red meat (see Table S3), calcium, fiber, 
folate, saturated fat, or poultry intake (data 
not shown). MeIQx, DiMeIQx, and MDM 
were not associated with CRC sub-sites, 
which included 155 proximal, 120 distal, 
and 87 rectal cases in men and 400 proximal, 
216 distal, and 159 rectal cases in women 
(numbers do not add up to 100% of all 
CRC cases in each cohort because for some 
cases the exact sub-site at which the tumor 
occurred was either ambiguous or missing, 
and the cases were excluded from the sub-site 
analysis; only cases with available sub-site 
data were included in this analysis). However, 
PhIP from red but not white meat was posi-
tively associated with risk of proximal cancers 
[per SD of log-transformed HCAs increase: 
pooled HR (95% CI) = 1.11 (1.02, 1.21), 
p = 0.02, Table 3]. The association between 
PhIP from red meat and rectal cancer was 
similar to that observed for proximal cancer 
but did not reach statistical significance 
[pooled HR (95% CI) = 1.10 (0.95, 1.27), 
p = 0.22, Table 3].
Associations were similar after we 
separately adjusted for total red meat (see 
Table S4), processed red meat, unprocessed 
meat, chicken, fish, saturated fat, folate, 
calcium, or fiber intake (data not shown). 
Positive associations between PhIP from red 
meat and proximal cancers also persisted 
Table 2. Hazard ratios (HR) (95% CIs) for colorectal cancer by quintiles (Q) of meat mutagen intake.
Exposure MeIQx PhIP total PhIP red meat PhIP white meat DiMeIQx MDM
Men (418 cases)
Age-adjusted
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.23 (0.90, 1.69) 1.13 (0.83, 1.54) 1.27 (0.91, 1.76) 1.09 (0.80, 1.47) 1.12 (0.78, 1.61) 1.13 (0.82, 1.54)
Q3 1.12 (0.81, 1.54) 1.22 (0.90, 1.65) 1.36 (0.98, 1.87) 1.25 (0.93, 1.69) 1.14 (0.87, 1.50) 0.99 (0.72, 1.37)
Q4 1.03 (0.75, 1.43) 1.33 (0.98, 1.80) 1.41 (1.02, 1.93) 1.12 (0.82, 1.52) 1.21 (0.92, 1.58) 1.30 (0.96, 1.76)
Q5 1.44 (1.07, 1.94) 1.13 (0.82, 1.57) 1.53 (1.10, 2.11) 1.17 (0.85, 1.61) 0.90 (0.67, 1.22) 1.15 (0.84, 1.57)
p for trend* 0.04 0.55 0.03 0.52 0.31 0.31
Multivariable adjusteda
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.16 (0.84, 1.59) 1.07 (0.78, 1.45) 1.22 (0.87, 1.70) 1.07 (0.79, 1.45) 1.12 (0.78, 1.62) 1.06 (0.77, 1.45)
Q3 1.01 (0.73, 1.40) 1.12 (0.82, 1.52) 1.26 (0.91, 1.75) 1.21 (0.89, 1.63) 1.12 (0.85, 1.47) 0.92 (0.67, 1.27)
Q4 0.92 (0.66, 1.28) 1.23 (0.90, 1.68) 1.28 (0.92, 1.77) 1.09 (0.80, 1.48) 1.14 (0.87, 1.49) 1.18 (0.86, 1.60)
Q5 1.22 (0.89, 1.68) 1.01 (0.72, 1.41) 1.31 (0.93, 1.84) 1.13 (0.82, 1.55) 0.88 (0.65, 1.19) 1.02 (0.73, 1.41)
p for trend* 0.35 0.97 0.27 0.66 0.24 0.84
Women (790 cases)
Age-adjusted
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 0.88 (0.69, 1.11) 1.19 (0.95, 1.48) 1.02 (0.81, 1.28) 1.10 (0.89, 1.35) 1.06 (0.84, 1.32) 0.84 (0.67, 1.05)
Q3 1.09 (0.88, 1.36) 1.27 (1.02, 1.58) 1.10 (0.87, 1.38) 1.05 (0.84, 1.30) 1.04 (0.83, 1.30) 0.99 (0.79, 1.23)
Q4 1.15 (0.93, 1.44) 1.25 (1.00, 1.57) 1.25 (1.00, 1.57) 1.13 (0.91, 1.41) 1.18 (0.94, 1.47) 1.14 (0.92, 1.42)
Q5 1.13 (0.91, 1.40) 1.19 (0.94, 1.49) 1.20 (0.96, 1.50) 0.91 (0.71, 1.15) 1.15 (0.93, 1.43) 1.09 (0.88, 1.35)
p for trend* 0.06 0.28 0.05 0.27 0.16 0.09
Multivariable adjusteda
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 0.86 (0.68, 1.09) 1.18 (0.94, 1.47) 1.02 (0.81, 1.28) 1.10 (0.89, 1.36) 1.06 (0.84, 1.32) 0.83 (0.66, 1.04)
Q3 1.06 (0.84, 1.32) 1.25 (1.00, 1.56) 1.08 (0.85, 1.36) 1.04 (0.83, 1.29) 1.04 (0.83, 1.30) 0.97 (0.77, 1.21)
Q4 1.11 (0.88, 1.38) 1.22 (0.97, 1.54) 1.23 (0.98, 1.54) 1.13 (0.91, 1.40) 1.18 (0.94, 1.47) 1.11 (0.89, 1.38)
Q5 1.07 (0.86, 1.34) 1.14 (0.90, 1.45) 1.15 (0.92, 1.45) 0.90 (0.71, 1.15) 1.15 (0.93, 1.43) 1.04 (0.83, 1.30)
p for trend* 0.19 0.49 0.14 0.26 0.16 0.23
Pooled age adjusted** (1,208 cases)
Q5 vs. Q1 1.25 (0.99, 1.57) 1.17 (0.97, 1.41) 1.31 (1.05, 1.65) 1.01 (0.79, 1.29) 1.04 (0.82, 1.32) 1.11 (0.93, 1.32)
p **,# 0.06 0.11 0.02 0.96 0.73 0.26
Pooled multivariable adjusteda,** (1,208 cases)
Q5 vs. Q1 1.12 (0.93, 1.34) 1.10 (0.90, 1.33) 1.20 (0.99, 1.45) 0.98 (0.80, 1.21) 1.01 (0.81, 1.24) 1.03 (0.86, 1.24)
p **,# 0.23 0.35 0.06 0.87 0.96 0.75
Q1 is the reference category.
aAdjusted for age (months), 2-year follow-up cycle, family history of colorectal cancer in first-degree relatives (yes vs. no), prior lower gastrointestinal endoscopy (sigmoidoscopy or 
colonoscopy; yes vs. no), pack-years of smoking before age 30 years (0, 0.1–4.9, 5–9.9, ≥ 10), body mass index (kg/m2: < 23, 23–24.9, 25–26.9, 27–29.9, ≥ 30), leisure time physical activity 
(MET-hours/week:< 3, 3–8.9, 9–17.9, 18–26.9, ≥ 27), regular aspirin or NSAID use (≥ 2 tablets/week), total caloric intake (quintiles), alcohol consumption (g/day: < 5, 5–9.9, 10–14.9, 
15–29.9, ≥ 30). *Test for trend was calculated by treating the median of each quintile of the exposure variable as a continuous variable in the model and using a Wald test to assess 
statistical significance. **All p for heterogeneity > 0.05. #p for trend was derived from random-effects meta-analysis.
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after adding heme iron intake [per SD of 
log-transformed HCA increase: pooled HR 
(95% CI): 1.12 (1.03, 1.23), p = 0.01] or 
MDM from red meat separately to the multi-
variable models [pooled HR (95% CI): 1.18 
(1.01, 1.37), p = 0.04] (data not shown).
After restricting analyses to cases diag-
nosed within the first 4 years of follow-up we 
observed positive associations between intake 
of PhIP from red meat, but not from white 
meat and CRC [highest vs. lowest tertile, 
pooled HR (95% CI): PhIP red meat 1.39 
(1.07, 1.79), p for trend = 0.01, PhIP white 
meat: 1.09 (0.74, 1.62), p for trend = 0.66; 
see Table S5]. However, results were based 
on a limited number of cases (255 in women 
and 133 in men). No association between 
intake of HCAs and MDM and risk of CRC 
were observed with longer latency periods 
(4–14 year lag).
In both men and women, associations 
between HCAs and CRC did not appear 
to differ by smoking status (never/ever) or 
family history of CRC (yes/no) with p for 
interaction > 0.05 (data not shown). There 
was a positive but nonsignificant association 
between PhIP intake and proximal cancers 
in overweight or obese men (BMI ≥ 25), 
but not in men with BMI < 25 [highest vs. 
lowest tertile, HR (95% CI), BMI ≥ 25: 2.35 
(1.29, 4.27), BMI < 25: 0.54 (0.27, 1.10), 
p for interaction = 0.07]. The association 
between PhIP and proximal cancers did 
not differ by BMI in women [highest vs. 
lowest tertile, HR (95% CI), BMI ≥ 25: 
1.20 (0.86, 1.69), BMI < 25: women: 0.98 
(0.64, 1.49), p for inter action = 0.50].
No significant positive associations 
between cooking methods or outside appear-
ance and risk of CRC was observed. Our 
results suggested a positive, albeit nonsignifi-
cant association between well-done pan-fried 
steak intake and CRC [data collected in 
women only: well-done vs. lightly browned 
1.38 (95% CI: 0.89, 2.15), p for trend = 0.07], 
but results were based on a small number 
of cases in the reference category (n = 26) 
(see Table S6).
Discussion
Results from these two large prospective 
cohort studies do not support the hypothesis 
that higher intake of heterocyclic amine intake 
per se substantially increases risk of CRC. 
However, we observed positive association 
between PhIP from red meat, but not from 
white meat, and proximal colon cancers. PhIP 
from red meat also was associated with CRC 
diagnosed during the first 4 years of follow-
up (1996–2000), but was not associated with 
CRC diagnosed 4–14 years after baseline.
Although red and processed meats are 
considered established risk factors for CRC 
and the 2007 World Cancer Research 
Fund/American Institute for Cancer Research 
(WCRF/AICR) and the 2001 Continuous 
Update Project (CUP) reports concluded 
that the evidence for a link between red and 
processed meat and CRC is “convincing,” 
little is known about underlying mechanisms 
(WCRF/AICR 2007, 2011). Recently, the 
IARC Monograph Working Group classi-
fied “the consumption of processed meat as 
carcinogenic to humans (Group 1) based 
on the sufficient evidence in humans that 
the consumption of processed meat causes 
colorectal cancer” (Bouvard et al. 2015). On 
the other hand, the IARC Working Group 
classified “the consumption of red meat 
as probably carcinogenic based on limited 
evidence that the consumption of red meat 
causes cancers and the strong mechanistic 
evidence (Group 2A).” Cooking meats can 
result in the production of mutagens such 
as polycyclic aromatic hydrocarbons (PAHs) 
or heterocyclic amines. PAHs are produced 
when there is incomplete combustion, and 
exposure to PAHs is also possible via the 
 environment (Cross and Sinha 2004).
Heterocyclic amines are formed when 
meats are cooked at high temperatures via 
reactions between amino acids, sugars, and 
creatine (Hodge 1953; Maillard 1912). More 
than 20 HCAs have been detected in cooked 
meats, and concentrations tend to increase 
with higher temperature and longer duration 
of cooking (Sugimura 1997, 2000; Turesky 
et al. 2007). In bacterial mutagenicity assays 
HCAs are mutagenic, and in animal studies 
both MeIQx and PhIP are very potent 
chemical carcinogens for multiple organs, 
including the colon (Kato et al. 1989; Ochiai 
et al. 1991; Ohgaki et al. 1986). PhIP is the 
most abundant HCA in the human diet, 
followed by MeIQx and DiMeIQx (IARC 
1993). In terms of mutagenicity, however, 
the order is reversed, with DiMeIQx being 
the most and PhIP the least potent mutagen 
(Sinha and Rothman 1997).
Only a few studies have examined the 
association between meat mutagens and 
risk of CRC, and the results are inconsis-
tent. For example, several U.S.-based case–
control studies on HCAs and CRC observed 
a positive association between HCA intake 
and CRC or colon cancer (Butler et al. 
2003; Helmus et al. 2013; Joshi et al. 2015; 
Le Marchand et al. 2002; Miller et al. 2013; 
Nowell et al. 2002), whereas a null associa-
tion was observed in other studies (Augustsson 
et al. 1999; Gilsing et al. 2012; Kobayashi 
et al. 2009). Differences in exposure assess-
ment such as type of questions on the cooking 
questionnaires, reference period of reported 
intake, and the use of different HCA data-
bases may at least partly explain those differ-
ential findings. For example, although the 
U.S.-based case–control studies (Butler et al. 
2003; Helmus et al. 2013; Joshi et al. 2015; 
Le Marchand et al. 2002; Miller et al. 2013; 
Nowell et al. 2002; Gilsing et al. 2012) used 
databases developed by Sinha and colleagues 
(for studies before 2006: Sinha 2002; Sinha 
and Rothman 1997; Sinha et al. 1995, 1998, 
2001; for studies after 2006: NCI 2006), 
the two non-U.S. case–control studies 
from Sweden and Japan (Augustsson et al. 
1999; Kobayashi et al. 2009) used databases 
accounting for cooking methods and culinary 
preferences in their respective populations 
(Skog et al. 1995; Kobayashi et al. 2009).
Two large prospective U.S.-based 
cohorts—the NIH-AARP Diet and Health 
Study (NIH-AARP) (Cross et al. 2010) and 
the Multiethnic Cohort Study (Ollberding 
et al. 2012)—have previously reported the 
association between HCAs per se and other 
meat mutagens and risk of CRC. In the 
Table 3. Pooled HR (95% CI) for CRC (per standard deviation increase of log-transformed meat mutagen 
intake) by sub-sites.
HCAs Proximal colon p*,** Distal colon p*,** Rectum p*,**
Cases men/women 155/400 120/216 87/159
Pooled age-adjusted
MeIQx 1.04 (0.96, 1.13) 0.33 1.02 (0.91, 1.13) 0.77 1.08 (0.95, 1.23) 0.24
PhIP total 1.07 (0.98, 1.17) 0.15 0.98 (0.89, 1.09) 0.76 1.04 (0.92, 1.19) 0.52
PhIP red meat 1.12 (1.02, 1.24) 0.02 0.98 (0.88, 1.09) 0.72 1.13 (0.98, 1.31) 0.10
PhIP white meat 1.00 (0.93, 1.09) 0.94 0.96 (0.87, 1.05) 0.35 0.97 (0.87, 1.09) 0.63
DiMeIQx 1.01 (0.92, 1.11) 0.82 1.05 (0.93, 1.18) 0.46 1.11 (0.96, 1.28) 0.14
MDM 1.04 (0.95, 1.14) 0.40 1.02 (0.92, 1.14) 0.69 1.02 (0.90, 1.15) 0.78
Pooled multivariable adjusteda
MeIQx 1.03 (0.94, 1.12) 0.52 0.97 (0.85, 1.10) 0.62 1.04 (0.91, 1.19) 0.59
PhIP total 1.07 (0.97, 1.17) 0.17 0.96 (0.86, 1.06) 0.41 1.02 (0.89, 1.16) 0.81
PhIP red meat 1.11 (1.02, 1.21) 0.02 0.94 (0.84, 1.05) 0.26 1.10 (0.95, 1.27) 0.22
PhIP white meat 1.00 (0.93, 1.09) 0.90 0.95 (0.85, 1.06) 0.33 0.96 (0.86, 1.07) 0.47
DiMeIQx 1.01 (0.92, 1.10) 0.88 1.02 (0.90, 1.16) 0.71 1.07 (0.93, 1.24) 0.34
MDM 1.03 (0.94, 1.13) 0.48 1.00 (0.89, 1.11) 0.96 0.99 (0.88, 1.12) 0.91
aAdjusted for age (months), 2-year follow-up cycle, family history of colorectal cancer in first-degree relatives (yes vs. 
no), prior lower gastrointestinal endoscopy (sigmoidoscopy or colonoscopy; yes vs. no), pack-years of smoking before 
age 30 (0, 0.1–4.9, 5–9.9, ≥ 10), body mass index (kg/m2: < 23, 23–24.9, 25–26.9, 27–29.9, ≥ 30), leisure time physical activity 
(MET-hours/week: < 3, 3–8.9, 9–17.9, 18–26.9, ≥ 27), regular aspirin or NSAID use (≥ 2 tablets/week), total caloric intake 
(quintiles), alcohol consumption (in g/day: < 5, 5–9.9, 10–14.9, 15–29.9, ≥ 30).
*All p for heterogeneity > 0.05. **p-Values were derived from random-effects meta-analysis.
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NIH-AARP study, which included 2,719 
CRC cases, a positive association between 
HCA intake and CRC was seen in the 
NIH-AARP study after 7 years of follow-
up (Cross et al. 2010). In that study, higher 
intake of DiMeIQx, MeIQx, and MDM 
but not PhIP was associated with higher risk 
of colon cancers, but no associations were 
observed for rectal cancers. In the Multiethnic 
Cohort Study (MEC), HCA intake was 
not associated with CRC (n = 1,757 cases) 
regardless of sub-sites (colon vs. rectum) 
after 15 years of follow-up (Ollberding et al. 
2012). It is unclear why associations in the 
NIH-AARP differ from those observed in the 
MEC and our study. All four cohorts used 
the CHARRED Database to estimate meat 
mutagen intake, and the age distribution of 
the study population at the time cooking 
questionnaires were administered did not vary 
considerably between those studies (NHS 
and HPFS in 1996, 50–75 years; MEC, 
45–75 years; NIH-AARP, 50–71 years).
However ,  fo l low-up t ime in  the 
NIH-AARP was shorter (7 years) than those 
in the other studies (MEC, 15 years; NHS and 
HPFS, 14 years). Furthermore, the majority 
of participants in the HPFS, NHS, and the 
NIH-AARP were white (> 90%) (Cross et al. 
2010), whereas the MEC study consisted 
of a more ethnically diverse population and 
included Japanese-Americans (29.5%), whites 
(26%), Latinos (21.3%), African Americans 
(15.9%), and Native Hawaiians (7.3%) 
(Ollberding et al. 2012). In addition, HPFS, 
NHS, and NIH-AARP participants were on 
average better educated than MEC participants 
(Kolonel et al. 2000; Schatzkin et al. 2001). 
Multivariable models in the three cohorts 
included a similar set of covariates consisting 
of known and suspected risk factors for CRC. 
However, although the NIH-AARP cohort 
and MEC cohort both adjusted for calcium 
and fiber intake, the final model in the MEC 
study also included folate and vitamin D 
intake. In our study, after including calcium, 
fiber, or folate intake separately to our final 
multivariable models, results were similar.
When analyzed by cancer sub-sites, PhIP 
from red meat, but not from white meat, was 
positively associated with proximal cancers, 
and associations remained similar after 
adjusting for red or processed meat intake. 
These findings are in agreement with those 
of a previous case–control study by Helmus 
et al. (2013), which also used the CHARRED 
Database to estimate meat mutagen intake; 
the authors observed positive associations 
between meat mutagen intake from red meat, 
but not from white meat and risk of CRC. 
However, in a multi-center case–control study 
by Kampman et al. (1999) a nonsignificant 
positive association between meat mutagen 
index (calculated by multiplying frequency 
of meat intake with doneness of meat intake) 
from white, but not red meat, and risk of 
colon cancer was observed in men, but not in 
women. In women, mutagen index from white 
or red meat was not associated with risk of 
colon cancer. Because the study by Kampman 
et al. (1999) did not estimate meat mutagen 
intake per se, it is not possible to compare the 
results between those two case–control studies.
It is unclear why PhIP from red but not 
from white meat is positively associated with 
risk of CRC in our study. Differential findings 
by source of meat suggest that PhIP intake 
by itself is likely not associated with CRC. 
It possible that PhIP from red meat may 
be a marker for some unknown mutagenic 
compound(s) related specifically to cooking 
of red meat or some compounds in red meat. 
Evidence for the presence of other previously 
unknown mutagens in cooked red meat comes 
from a recent study, which identified a novel 
HCA—2-amino-1,7-dimethylimidazo[4,5-g]
quinoxaline (7-MeIgQx)—in cooked beef. 
In grilled beef patties the concentration of 
7-MeIgQx was comparable with that of PhIP 
or even higher (depending on the cooking 
temperature) (Turesky et al. 2007). The 
CHARRED Database does not provide data 
on 7-MeIgQx. However, in our study, results 
for PhIP from red meat and proximal cancers 
were similar after adding intake of total red 
meat, heme iron, or MDM from red meat (a 
marker for total mutagenic activity) to our 
multivariable models.
HCAs are mutagens and can form DNA 
adducts, but their potential role, if any, at 
different stages (i.e., during earlier vs. later 
stages) during colorectal carcinogenesis 
remains unknown (Cross and Sinha 2004). 
In our study, positive associations for PhIP 
from red meat were restricted to cases diag-
nosed within the first 4 years of follow-up 
(1996–2000). Interestingly, adenoma studies 
have generally observed positive associations 
between meat mutagen intake and risk of 
adenoma or adenoma recurrence, particularly 
distal adenoma, even though findings relating 
meat mutagens to stage or size of adenoma are 
inconsistent (Martinez et al. 2007; Rohrmann 
et al. 2009; Sinha et al. 2005). Reverse causa-
tion resulting from changes in diet due to 
symptoms related to undiagnosed CRC may 
also explain these findings. However, we would 
expect that sympto matic participants would 
decrease rather than increase their intake 
of well-done/charred red meat. Our results 
were based on a limited number of cases and 
we cannot exclude the possibility that the 
 aforementioned findings are due to chance.
Other possible mechanisms through 
which red meat consumption can increase 
risk of CRC include heme iron (Bastide et al. 
2015), which is higher in red than in white 
meat, and may also facilitate endogenous 
nitrosation (i.e., the production of carci-
nogenic N-nitroso compounds) (Cross and 
Sinha 2004). In a previous study from our 
group using data from the NHS and HPFS 
in women, our findings were suggestive of 
a positive, albeit nonsignificant association 
between heme iron intake and CRC [highest 
vs. lowest quintile: HR = 1.21 (95% CI: 
0.96, 1.52) p for trend = 0.10]. In men, 
however, heme iron intake was not associated 
with risk of CRC (Zhang et al. 2011).
The strengths of our study include its 
prospective design, the large sample size and 
long follow-up of 14 years, as well as the avail-
ability of detailed and repeated assessment of 
diet and lifestyle factors through our follow-
up questionnaires, which enabled us to adjust 
for a variety of potential confounders and 
examine associations by sub-sites as well as 
conduct latency analyses. Although we were 
able to detect positive associations, we cannot 
exclude the possibility of misclassification of 
exposure. Nondifferential misclassification 
of exposure (e.g., highest vs. lowest quintile 
of meat mutagen intake) generally attenuates 
associations toward the null, which may at least 
partly explain our null findings. For example, 
our results were based on a one-time assess-
ment of HCA intake, and we were not able 
to account for factors that can change HCA 
content in cooked meats, such as frequent 
flipping of meat during grilling or frying (Tran 
et al. 2002), use of marinades (Salmon et al. 
1997), microwaving meats before cooking 
(Felton et al. 1994), or removing the charred 
portion of meat before eating.
Furthermore, HCAs by themselves are 
not carcinogenic and require metabolic acti-
vation via xenobiotic metabolizing enzymes 
(XME) (Boobis et al. 1994; Chou et al. 1995; 
Minchin et al. 1992). However, we did not 
assess associations by genetic susceptibility. 
Only a few epidemiological studies have 
examined interactions between HCA intakes 
per se and single-nucleotide polymorphisms 
in XME with regard to risk of CRC, and 
findings are inconclusive (Butler et al. 2008; 
Gilsing et al. 2012; Kobayashi et al. 2009; 
Nöthlings et al. 2009). Another source for 
potential misclassification is that HCA intake 
was estimated based on a limited number of 
questions. However, cooking method ques-
tions were based on a previous pilot study, 
which established the set of questions to 
enhance estimation of HCA intake in our 
cohorts (Byrne et al. 1998). Further, as with 
every observational study we can never exclude 
the possibility of residual confounding.
In conclusion, estimated intakes of meat 
mutagens were not significantly associated 
with CRC risk over 14 years of follow-up in 
the NHS and HPFS cohorts. Results for PhIP 
from red but not from white meat warrant 
further investigation.
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